Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Nahed Hammadieh (nahed_hammadieh@hotmail.com), clinical research fellow in reproductive medicine,
  2. Khaldoun Sharif, consultant obstetrician and gynaecologist,
  3. Masoud Afnan, consultant obstetrician and gynaecologist,
  4. Spyros Papaioannou, clinical research fellow in reproductive medicine,
  5. Bolaride Ola, clinical research fellow in reproductive medicine
  1. Assisted Conception Unit, Birmingham Women's Hospital, Birmingham B15 2TG

    EDITOR—Bone marrow transplantation is used in several haematological diseases, such as acute and chronic leukaemia, aplastic anaemia, and severe congenital immunodeficiencies.1 The survival rate has improved greatly over the past decade.2 Patients who have had successful bone marrow transplantation have peripheral blood cells originating from the donated bone marrow, and results of cytogenetic studies of these blood cells will relate to the donor. This is an important point to note if confusion is to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular